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The circadian clock is entrained to environmental
cycles by external cue-mediated phase adjustment.
Although the light input pathway has been well
defined, the mechanism of feeding-induced phase
resetting remains unclear. The tissue-specific sensi-
tivity of peripheral entrainment to feeding suggests
the involvement of multiple pathways, including hu-
moral and neuronal signals. Previous in vitro studies
with cultured cells indicate that endocrine factors
may function as entrainment cues for peripheral
clocks. However, blood-borne factors that are well
characterized in actual feeding-induced resetting
have yet to be identified. Here, we report that insulin
may be involved in feeding-induced tissue-type-
dependent entrainment in vivo. In ex vivo culture ex-
periments, insulin-induced phase shift in peripheral
clocks was dependent on tissue type, which was
consistent with tissue-specific insulin sensitivity,
and peripheral entrainment in insulin-sensitive tis-
sues involved PI3K- and MAPK-mediated signaling
pathways. These results suggest that insulin may
be an immediate early factor in feeding-mediated tis-
sue-specific entrainment.INTRODUCTION
The circadian clock is driven by cell-autonomous clock gene
expression rhythms in almost all organisms (Reppert and
Weaver, 2002; Rosbash et al., 2007). The core circadian tran-
scriptional feedback loop generates circadian expression of a
wide range of numerous genes, which in turn leads to circadian
oscillation in diverse physiological processes (Doherty and Kay,
2010; Mohawk et al., 2012). The circadian clock enables
maximum expression of genes at appropriate times of the day,
allowing organisms to adapt to earth rotation. It has been re-
ported that chronic desynchronization between physiological
and environmental rhythms carries a significant risk of diverse
disorders, ranging from sleep disorders to diabetes, cardiovas-cular diseases, and cancer (Sahar and Sassone-Corsi, 2012;
Wijnen and Young, 2006). Thus, a thorough understanding of
the mechanism of the circadian input pathway is critically impor-
tant to the prevention of diseases. The circadian input consists of
two major pathways. The first is the light input pathway via the
hypothalamic suprachiasmatic nuclei (SCN), known as the circa-
dian pacemaker. Details of this mechanism have been eluci-
dated at the molecular level by a substantial number of studies
(Doyle and Menaker, 2007). The second is the feeding input
pathway (Damiola et al., 2000; Stokkan et al., 2001), for which
a factor has yet to be identified and characterized in vivo. Tem-
poral feeding restriction changes the phase of circadian gene
expression in peripheral tissues without affecting the phase in
the SCN, and food-induced phase resetting proceeds much
faster in the liver than in the kidney, heart, or pancreas (Damiola
et al., 2000). The tissue-specific sensitivity of peripheral entrain-
ment to feeding suggests the involvement of multiple pathways,
including humoral and neuronal signals.
The circadian clock is cell-autonomous (Nagoshi et al., 2004;
Yamazaki et al., 2000), and much can therefore be learned
from studies using cultured cells. Indeed, cell line-based exper-
iments to elucidate the entrainment mechanism have been per-
formed. A number of endogenous factors are reported to act on
cell-autonomous circadian gene expression in cultured cell lines,
including growth factors, calcium, glucose, angiotensin II, reti-
noic acid, and nitric oxide (Akashi and Nishida, 2000; Balsalobre
et al., 2000; Hirota et al., 2002; McNamara et al., 2001; Nonaka
et al., 2001). In addition, insulin, a humoral factor that regulates
blood glucose levels, also has effects on clock gene expression
in cultured cell lines (Balsalobre et al., 2000; Yamajuku et al.,
2012). With regard to in vivo relevance, mice carrying pharmaco-
logically damaged beta cells show altered expression of clock
genes in peripheral tissues (Kuriyama et al., 2004; Oishi et al.,
2004), indicating the presence of in vivo interaction between
the circadian clock and insulin signaling. However, the physio-
logical role of insulin in the circadian clock remains to be
determined.
The pancreas secretes insulin in response to feeding. We
speculated that insulin acts as an endogenous molecule
required for feeding-induced tissue-specific phase resetting of
peripheral clocks. To help elucidate the in vivo roles of insulin
in feeding-induced circadian entrainment, we used in vivo
imaging experiments to examine expression levels of Per2 inCell Reports 8, 393–401, July 24, 2014 ª2014 The Authors 393
Figure 1. In Vivo Monitoring of Peripheral Tissues from Individual Animals during Restricted Feeding
(A–C) Per2-luciferase (Per2Luc) mice during the restricted feeding schedule were monitored with an in vivo imaging system. Feeding schedule (A, left). Per2Luc
mice received food during the nighttime (21:00–9:00; light on at 9:00 and off at 21:00) for 1 week and then had restricted food access for 6 hr (9:00–15:00) under
continuous dark conditions. Black-and-white bars represent light-dark (LD) conditions. Pink shadow represents feeding time. Images were taken at the time
indicated by the black triangles. Right, representative in vivo images from the ventral aspect. Yellow arrowheads denote the submandibular gland (Sub Gla).
(B) Averaged quantitative data of Sub Gla and the liver from (A). Rhythmic expression of Per2 in the liver was entrained to restricted feeding, although not in the
Sub Gla. *p < 0.05, **p < 0.01 versus corresponding nighttime. The data represent the mean ± SE (n = 8).
(C) Individual quantitative data of liver from (A).individual animals around the clock in the presence of a highly
specific competitive peptide inhibitor of insulin. To exclude the
possibility that the results were affected by secondary effects
of the inhibitor, we used ex vivo approaches. We therefore con-
ducted ex vivo tissue culture experiments to examinewhether in-
sulin-induced phase shift in peripheral clocks depends on tissue
type, consistent with the tissue-specific sensitivity of insulin.
RESULTS AND DISCUSSION
Evaluation of peripheral clocks requires the preparation of a
large number of animals, harvesting of tissues every few hours,
and examination of clock gene expression levels using purified
RNA. These experimental procedures are arduous, but provide
no information about sequential changes in clock gene expres-
sion in individual animals. Rather, the data only show average
expression levels from several dead animals. In contrast, a
recent in vivo imaging technique enables detection of sequential
changes in clock gene expression levels in individual animals394 Cell Reports 8, 393–401, July 24, 2014 ª2014 The Authorswithout killing them (Tahara et al., 2012). Hence, using in vivo
imaging of individual Per2-luciferase knockin mice (Yoo et al.,
2004), we investigated temporal changes in Per2 expression
rhythms in peripheral tissues of individual animals (Figure 1A,
top). About 10 min after subcutaneous injection of luciferin,
strong luminescence was detected in the liver and submandibu-
lar gland. We were then able to confirm circadian gene expres-
sion of Per2 in these tissues by time course measurement
around the clock. Furthermore, to observe feeding-induced
phase shift of circadian gene expression, we changed the
feeding schedule from ZT12-24 to ZT0-6, and 5 days later
observed antiphase expression of Per2 in the liver (Figure 1A,
right). In contrast, this phase shift was subtle in the subman-
dibular gland (Figures 1A and 1B), suggesting that there are sig-
nificant differences among peripheral tissues in the rate of
feeding-induced phase shift. The phase change in individual
animals is shown in Figure 1C. While Per2 expression in each
animal’s liver showed a similar and reproducible response to
the restricted feeding, minor variation among individuals was
Figure 2. Involvement of Insulin in Feeding-Induced Circadian Phase Shift in the Liver
(A) Acute induction of Per2 transcripts after feeding was blocked by S961. Per2 mRNA expression levels in liver at ZT2 (60 min after feeding onset) were
determined with RT-PCR. Each value was normalized with b-actin. The data represent the mean ± SE (n = 3). *p < 0.05.
(B) Representative in vivo image of Per2Lucmice liver injected with S961 30 min before the start of feeding every day during restricted feeding. S961 inhibited the
entrainment of Per2.
(C) Quantitative data of bioluminescence in the liver from (B). The data represent the mean ± SE (n = 8). **p < 0.01.
(D) Acrophases in a representative animal from (B) were calculated by a cosine curve fitting. The data at right represent the mean ± SE (n = 8).
(E) Quantitative RT-PCR of Per2,Bmal1, andRev-erbamRNA in the liver during RF (ZT1-7) in LD; n = 2. Black circles represent individual values ofmice given PBS
mice and green circles represent mice given S961. S961 was used at a concentration of 30 nmol/kg in all experiments.apparent in the rate of the phase shift. The pancreas secretes
insulin in response to feeding, and peripheral tissues show
different sensitivity to insulin, indicating why the liver clock, but
not the submandibular gland clock, was immediately phase-
adjusted by restricted feeding. These results demonstrate that
in vivo imaging technology is a powerful tool in investigating
sequential and temporal changes in peripheral clocks in
individuals.
It was reported that restricted feeding triggers a rapid transient
induction of Per2 transcription in the liver (Wu et al., 2010). The
immediate early expression of Per2 would likely affect the nega-
tive feedback loop in circadian transcription because Per2 is a
component of the negative limb. If insulin is indispensable to
feeding-induced resetting, inhibition of insulin signaling shouldresult in attenuation of thePer2 expression levels rapidly induced
by restricted feeding (Figure 2A). To inhibit insulin action during
feeding-induced phase shift without pharmacologically killing
beta cells, mice received a subcutaneous injection of S961, a
highly specific competitive peptide inhibitor of insulin, prior to
feeding (Scha¨ffer et al., 2008; Scherer et al., 2011; Vikram and
Jena, 2010). S961-injected animals ate a similar amount of
food as control animals. As expected, this pretreatment with
S961 potently inhibited the rapid transient induction of Per2 by
restricted feeding. Next, using an in vivo imaging system, we
examined whether S961 suppresses the feeding-induced circa-
dian phase shift of Per2 expression rhythm in the liver of individ-
ual animals (Figure 2B). In the control animals, transition states of
Per2 expression rhythms were confirmed in each animal’s liverCell Reports 8, 393–401, July 24, 2014 ª2014 The Authors 395
approximately 2 days after the inversion of feeding time. During
the process of transition, individual differences in phase change
were observed: some animals showed lower amplitudes of oscil-
lation temporarily, whereas others had a second peak (Fig-
ure S1). Average transition states of eight animals are shown in
Figure 2C. Compared with the control animals, animals pre-
treated with S961 showed a significant delay in phase shift on
day 2, and phase adjustment was still not completed on day 4
(Figures 2B–2D). When we processed data from individual
animals using a cosine curve fitting and calculated and quanti-
fied peak times (Figure 2D), we found that the shift speed of
acrophase appeared to be attenuated in animals pretreated
with S961.
A limitation of the present in vivo imaging approach is that it
provides no information on expression levels of genes other
than Per2. We therefore harvested the livers every 4 hours in
the conventional manner and confirmed the effect of S961 on
feeding-induced phase shift of clock gene oscillations with RT-
PCR (Figure 2E). As is the case with the in vivo imaging data,
circadian phase shift of the Per2, Bmal1, and Rev-erba genes
was significantly delayed compared with control animals. Sam-
pling in this experiment was performed under light-dark condi-
tions, but Per2 expression results were similar to the in vivo
imaging data obtained under dark-dark conditions (Figure 2B).
Furthermore, the S961-treated mice weighed almost the same
as the control mice throughout the experiment (Figure S2A).
Because S961 treatment provoked transient hyperglycemia (Fig-
ure S2B), we used an ex vivo slice culture system to confirm that
this hyperglycemia had no substantial influence on the effect of
S961 on insulin-induced circadian phase shift (Figure S3).
These data illustrate that the inhibition of insulin signaling
attenuates feeding-induced phase adjustment of the liver clock
in individual animals. As mentioned above, S961 potently in-
hibited the transient induction of Per2 that was triggered by
restricted feeding, whereas the phase shift of Per2 expression
rhythms was less strongly affected. This suggests that the tran-
sient induction may contribute to the phase shift, but is not abso-
lutely required for it, and that other unknown endogenous factors
are involved in the process.
There is no doubt that S961 treatment is a superior experi-
mental approach for investigating the physiological role of insulin
compared with methods using streptozotocin-treated, ob/ob or
db/db mice. However, it is impossible to completely exclude the
possibility that various secondary physiological events caused
by S961-induced transient hyperglycemia may affect feeding-
induced circadian phase shift. To exclude these secondary
effects and examine the true contribution of insulin to the circa-
dian phase shift, ex vivo or in vitro experimental approaches are
required for further validation. We therefore conducted ex vivo
culture experiments to investigate the effect of insulin on auton-
omous circadian gene expression. Per2 expression rhythms in
the liver were phase-shifted by the administration of insulin,
and the effect was then almost completely inhibited in the pres-
ence of S961, suggesting that insulin acted on the liver clock in a
receptor-specific manner (Figure 3A). Additionally, given the
well-known decrease in insulin sensitivity in the fatty liver, we
examined the effect of insulin on Per2 expression rhythm in livers
harvested frommice fed a high-fat diet (Figure 3B). As expected,396 Cell Reports 8, 393–401, July 24, 2014 ª2014 The Authorsthe insulin-induced phase shift in circadian gene expression was
smaller in fatty livers than in healthy livers. We found a phase de-
pendency in the insulin-mediated phase change of Per2 expres-
sion rhythms in the liver (Figure 3C). Insulin caused a phase
advance effect during the increasing phase of Per2 expression,
but a phase delay effect during the decreasing phase. Unexpect-
edly, the phase responsiveness observed on continuous admin-
istration of insulin was similar to that with 1 hr treatment with
insulin (Figure 3C, right versus left), indicating the presence of
a negative feedback mechanism for blocking continuous activa-
tion of the signaling pathway leading to the core clock. We con-
structed a dot-plot of phase responsiveness on administration of
insulin at various circadian phases (Figure 3D). The data indicate
that the direction of phase change of peripheral clocks depends
on the feeding time of day. To confirmwhether the phase shift by
insulin is consistent with this tissue insulin sensitivity, we exam-
ined the tissue-specific effect of insulin on autonomous Per2
expression rhythms ex vivo by performing slice culture of various
peripheral tissues (Figure 3E). As expected, we confirmed a large
phase shift of Per2 oscillation not only in liver, but also in adipose
tissue, both of which are insulin-sensitive. In contrast, insulin
exerted no or only a subtle effect in insensitive tissues, including
the lung, aorta, and submandibular gland.
On the assumption that the insulin-induced phase shift is in
fact dependent on insulin receptor expression, we speculated
that ectopic overexpression of the insulin receptor may confer
a degree of insulin sensitivity to receptor-poor cells. To test
this notion, we introduced an insulin receptor expression
plasmid vector into NIH 3T3 fibroblasts, a receptor-poor cell
line (Figure 4A). Insulin receptor overexpression was constitu-
tively driven by the AG promoter. In cells transfected with the
empty vector, insulin did not trigger a phase shift in Bmal1
expression rhythm (here using a Bmal1 promoter-driven lucif-
erase expression vector), but did induce a phase shift in cells
ectopically overexpressing the insulin receptor. Interestingly,
we found a phase difference in insulin sensitivity in spite of
constitutive overexpression of the receptor; insulin administra-
tion caused a phase advance during the decreasing phase of
Bmal1 (the increasing phase of Per2), as shown in the liver,
versus a phase delay in the increasing phase (Figure 4B). This
may indicate that phase-dependent insulin action might be ex-
plained in terms of the internal clock, independently of diurnal
changes in receptor expression levels. On the other hand, we
found that mRNA levels of the liver insulin receptor showed a
clear circadian pattern with an opposite phase to Per2 (Fig-
ure S4A), as indicated previously, which might have contributed
not to the direction but rather to the intensity of the insulin-
induced phase shift.
To examine whether transient activation of Per2 transcription
is sufficient to induce circadian phase shift in a phase-directed
manner, we introduced an isopropyl-b-D-thiogalactopyranoside
(IPTG)-inducible expression system to two cell lines, NIH 3T3
and U2OS (Figures 4C and 4D). In this culture system, whereas
ectopic expression of Per2 is suppressed by a lac repressor in
the absence of IPTG, it can be rapidly activated by administration
of IPTG without extracellular physiological stimuli and indepen-
dently of any intracellular signaling pathways. A 1-hr administra-
tion of IPTG caused a 1.5-hr phase delay during the increasing
Figure 3. Insulin-Mediated Circadian Phase Shift of Per2 Expression Rhythms in Insulin-Sensitive Tissues
(A–E) Explants derived from Per2Luc mice were treated with insulin at specific phases. Bioluminescence was measured in real time.
(A) Representative data of liver explants pretreatedwith 200 nMS961 from 30min before administration of insulin. Gray shadows represent the presence of insulin
and S961 in culture media.
(B) Oil Red O staining and representative data of explants derived from high-fat diet (HFD)-fed Per2Luc mice. Gray shadows represent the presence of insulin in
culture media. CV, central vein; NC, normal control.
(C) Phase-dependent alteration of mice liver explants with insulin. Experiments with a transient treatment (1 hr) of insulin are shown on the left, and experiments
with a continuous treatment at right. Gray shadows represent the presence of insulin in culture media. Representative data are shown.
(D) Phase response plot of time interval between peaks in liver from (C).
(E) Representative data and phase response plot of time interval between peaks of insulin-administered submandibular gland (Sub Gla), lung, aorta, and white
adipose tissue (WAT). All explants were treated with dexamethasone (Dex) and the second peak after Dex treatment was defined as peak2 (*), and the next peak
as peak3. Peak2-time was referred to as time = 0. Peak interval was calculated from the time difference between peak4 and peak2. Arrowheads indicate the time
of administration. For the analysis of slices other than WAT, data were detrended by subtracting a 24 hr running average from raw data.
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Figure 4. Acquisition of Insulin Sensitivity by Ectopic Receptor Expression and Phase-Dependent Circadian Phase Shift by Transient In-
duction of Per2
(A) NIH 3T3 fibroblasts were transfected with the Bmal1-driven luciferase and human insulin receptor a (hIRa) subunit expression vectors, and then stimulated
with 60 nM insulin or vehicle. Arrowheads indicate the time of administration. To synchronize cellular clocks, the cells were treated with 50 nM dexamethasone
more than 24 hr before insulin stimulation.
(B) Phase differences were calculated by comparing the first peak or trough after administration of insulin. DL, delay phase administration (increasing phase of
Bmal1 expression); ADV, advance phase administration (decreasing phase of Bmal1 expression). Data are represented as the mean ± SE for triplicate samples.
(C and D) NIH 3T3 and U2OS cells were transfected with the Bmal1-driven luciferase vector and a Lac repressor-expressing vector in the presence or absence of
an IPTG-inducible Per2 expression vector. The cells were treated with 50 nM dexamethasone (2 hr) to synchronize cellular clocks. Bmal1 transcription was
monitored in real-time using a cell culture-based luminescent monitoring system in the presence of luciferin. Approximately 18–20 hr (decreasing phase ofBmal1
expression, for ‘‘phase advance’’ experiments) or 30–32 hr (increasing phase of Bmal1 expression, for ‘‘phase delay’’ experiments) after the dexamethasone
shock, 2 mM IPTGwas added to the culture media to induce Per2 for 1 hr. Arrows indicate the time of administration. One hour after the administration, IPTGwas
removed.
(E and F) Phase differences were calculated by comparing the first peak or trough after administration of IPTG. Data are represented as the mean ± SE for
triplicate samples. DL, delay phase administration (increasing phase of Bmal1 expression); ADV, advance phase administration (decreasing phase of Bmal1
expression).
(G andH) Liver andwhite adipose tissue (WAT) explants fromPer2Lucmicewere pretreatedwith 50 mMLY294002 (LY) or 20 mMU0126 (U) before administration of
insulin. Explants were incubated with insulin for 2 hr. The data represent the mean ± SE. Gray shadows represent the presence of insulin and inhibitors in culture
(legend continued on next page)
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phase of Bmal1 (decreasing phase of Per2), versus a 1.5-hr
phase advance in the decreasing phase, in both the cell lines
(Figures 4E and 4F). Although the magnitude of phase shifts
was not particularly large when compared with the insulin-
induced phase shift in the liver, the direction of the phase shifts
by insulin treatment was reproduced by simply inducing ectopic
expression of Per2. These results support the possibility that
the phase responsiveness is explained in terms of the internal
clock, independently of any extracellular stimuli or intracellular
signaling pathways.
Activation of the insulin receptor leads to cellular glucose
uptake through the glucose transporter GLUT4, and activation
of the phosphoinositide 3-kinase (PI3K) and mitogen-activated
protein kinase (MAPK) signaling pathways. Previous reports
suggest that these intracellular events may be involved in the
resetting of clock gene expression in cultured cells. In Rat-1
fibroblasts, circadian gene expression is affected by treatment
with a high concentration of glucose (Hirota et al., 2002). In
H4IIE rat hepatoma cells treated with insulin, the MAPK and
PI3K signaling pathways are involved in a rapid and transient in-
duction of the Per1 and Per2 genes, respectively (Yamajuku
et al., 2012). Although the insulin-independent glucose trans-
porter GLUT2 is the main glucose transporter in the liver, we
confirmed the ability of insulin to phase-shift circadian gene
expression in the presence of cytochalasin B or D, an inhibitor
of the glucose transporter GLUT4 (Figure S4B). As expected,
cytochalasin treatment did not show any obvious effect on the
insulin-mediated circadian phase shift. Next, we examined the
effect of a PI3K inhibitor (LY294002) and a MEK inhibitor
(U0126) on insulin-induced circadian phase shift in ex vivo-
cultured liver (Figure 4G). Although U0126 showed no significant
effect on insulin activity, inhibition of the PI3K pathway resulted
in a significant attenuation of circadian phase shift. Unexpect-
edly, we also found that inhibition of the MAPK pathway, but
not the PI3K pathway, led to an attenuation of circadian phase
shift in white adipose tissue (Figure 4H), suggesting that the
intracellular signaling pathways for insulin-mediated phase shift
are tissue-specific. Our previous report indicated that the MAPK
pathway is sufficient for resetting cell-autonomous circadian
gene expression (Akashi and Nishida, 2000).
Together, these results indicate that not only the PI3K
pathway, but also the MAPK pathway are involved in insulin-
mediated circadian phase shift in insulin-sensitive tissues.
Together, the data from our in vivo studies and ex vivo assays
indicate that feeding causes circadian phase shift dependent
on insulin via PI3K- and MAPK-mediated induction of Per2 in a
phase-specific manner (Figure S4C).
Peripheral clocks enable autonomous circadian gene expres-
sion in a tissue-specific manner. Just like radio-controlled
clocks, the SCN functions as a standard clock, and then adjusts
peripheral clocks to prevent internal desynchronization. In
contrast, feeding acts on peripheral clocks as a zeitgeiber, inde-
pendently of the SCN. Our results indicate that insulin may bemedia. For synchronization of cellular clocks, all explants were treated with 100 n
peak2 (*) and the next peak as peak3. Peak2-time was referred to as time = 0. Pe
Arrowheads indicate the time of administration. For the analysis of slices other
raw data.one of the immediate early factors required for feeding-mediated
entrainment. The internal clock in insulin-sensitive tissues is
rapidly phase-shifted by feeding, and secondary factors such
as intratissue communication then gradually adjust the clock
phase of other peripheral tissues. However, the physiological
significance of this stepwise entrainment of peripheral clocks
remains undefined. In the SCN, the ventrolateral region is imme-
diately entrained to a new light-dark cycle, whereas the dorso-
medial region is gradually phase-adjusted by intercellular
communication with the ventrolateral region (Nagano et al.,
2003). The significance of the heterogeneity of the SCN is that
it successfully combines the flexible response to the external
environment with the robustness of the circadian system. The
heterogeneous sensitivity to feeding among peripheral clocks
might have a similar significance as the SCN. Furthermore, the
present data might have clinical importance: in therapy for
circadian disorders, they might provide valuable information for
effective phase adjustment of the circadian clock by dietary
manipulation. In addition, they suggest that the phase adjust-
ment of peripheral clocks might not work well in patients with
insulin resistance, and that medical staff might need to consider
the side effect of insulin treatment on the circadian clock in
diabetes care.
EXPERIMENTAL PROCEDURES
Feeding Schedule
After 1 week of nighttime feeding (ZT12-24; last day was termed day 0), mice
were fasted for 1 day, followed by restricted feeding for 6 hr per day for 6
consecutive days (from day 1 to day 7). Food was restricted from 9:00 to
15:00 under constant dark conditions for in vivo monitoring and from 10:00
to 16:00 (ZT1-7) under light-dark conditions for RT-PCR. For injection of
S961, the animals were injected with each solution subcutaneously on the dor-
sal neck at a dose of 30 nmol/kg at 30 min before the start of feeding every day
during the restricted feeding. For feeding stimulus, male ICR mice were fasted
for 24 hr and fed from ZT1 with a preinjection of saline or 100 nmol/kg of S961
on ZT0.5. All experiments were performed in accordance with the rules of the
Yamaguchi University Animal Usage Committee.
In Vivo Monitoring
In vivo monitoring utilized a Lumazone CMS imaging system (NipponRoper).
The animals were injected with D-luciferin potassium salt (Promega) subcuta-
neously on the back near the neck at a dose of 8.3 mg/kg (25mg/10 ml, 0.1 ml/
30 g body weight). Images were then taken at 8 min after luciferin injection with
1 min exposure from the ventral aspect while under anesthesia with isoflurane
(DS Pharma Animal Health) inside a black box. Images were obtained seven
times a day (ZT 2, 6, 10, 14, 18, 22, and 26). Mice were returned to their
home cages after each imaging procedure and recovered quickly from
anesthesia. The total time under anesthesia was approximately 20 min per
experiment.
In Vivo Monitoring Data Analysis
The bioluminescence emitted from each organ (liver, submandibular gland)
was calculated using the Metamorph (NipponRoper). For individual organs,
the region of interest was set to the same shape and size for the same organ
throughout all experiments. The averaged photon/sec value of the data from
the seven time points for days 0–1 was designated as 100%, and theM dexamethasone (Dex). The second peak after Dex treatment was defined as
ak interval was calculated from the time difference between peak3 and peak2.
than WAT, data were detrended by subtracting a 24 hr running average from
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bioluminescence rhythm for the entire day was expressed as a percentage of
each set of seven time points for the individual organs. The peak phase and
amplitude of this normalized percentage data were determined with the single
cosinor procedure program (Acro.exe, version 3.5; designed by Dr. Refinetti).
Lower goodness of fit scores indicate stable states of circadian oscillation,
whereas higher scores indicate transition states.
Preparation of Slice
Per2 Luc knockin mice were killed and used to make 300-mm thick slices from
liver, lung, and submaxillary gland with a McILWAIN tissue chopper, and white
adipose tissue was prepared from epididymal tissue and aorta with a stainless
steel surgical blade #11 (Feather) in ice-cold Hank’s balanced salt solution
(#14025, Life Technologies) with 10 mM HEPES (#H0887, Sigma-Aldrich).
Each slice was cultured with millicell (#PICMORG, Merckmillipore) in
Dulbecco’s modified Eagle’s medium (DMEM; #D2902, Sigma-Aldrich) with
0.035% sodium bicarbonate (S8761, Sigma-Aldrich), 10 mM HEPES
(#H0887, Sigma-Aldrich), 4.5 g/l D-glucose (#G8769, Sigma-Aldrich), 1.0%
penicillin-streptomycin (#15070-063, Life Technologies), 10% FBS (#04-001-
1A, Biological Industries), and 0.1 mM D-luciferin (Promega). Note that
DMEM (#D2902) basically includes 1.0 g/l of glucose, and a total of 4.5 g/l of
D-glucose. For low-glucose culture, slices were cultured in no-glucose
DMEM (#D5030, Sigma-Aldrich) with 0.035% sodium bicarbonate (S8761),
10 mM HEPES (#H0887), 1.0% penicillin-streptomycin (#15070-063), 1 mM
sodium pyruvate (#S8636, Sigma-Aldrich), 4 mM L-glutamine (#16948-04,
Nakalai Tesque), 10% FBS (#04-001-1A), and 0.1 mM D-luciferin (Promega).
All explants were treated with 100 nM dexamethasone (Dex) for 60–90 min
at 24–48 hr after preparation. Biological luminescence was measured and
integrated for 1 min at intervals of 15 min with a LM2400 (Hamamatsu
Photonics). Peak2-time was considered as time = 0 and administration of in-
sulin or vehicle was performed at a specific time. Pretreatment was started
from 15 min before insulin.
Analysis for Slice
For the analysis of the slices other than white adipose tissue, the original data
(1 min bins) were subtracted with 24 hr running average from the raw data.
In the case of white adipose tissue, the analysis did not work successfully,
due to the strong intensity and long duration of insulin-induced transient induc-
tion of the Per2 gene. Peak interval was calculated from the time difference
between peak4 and peak2. The value of peak2 was considered as 100 and
value of trough time just before peak2 was set as 0.
NIH 3T3 Analysis
The hBmal1 promoter regions were isolated and cloned into the pGL3-Basic
vector (Promega; Akashi and Takumi, 2005). NIH 3T3 cells were cultured
and transfected with a Bmal1::luciferase (Bmal1::luc) expression vector and
with or without a human insulin receptor alpha (AG promoter::hIRa) expression
vector, and incubated for 24 hr. Two hours after 50 nM dexamethasone treat-
ment, the medium was replaced with normal culture medium. In the presence
of 0.1 mM luciferin, light emission was measured and integrated for 1 min
at intervals of 15 min with a photomultiplier tube LM2400 (Hamamatsu
Photonics). Bioluminescence was processed through a 24 hr moving average
and expressed as a percentage value, with the first peak value designated
as 100.
Real-Time Monitoring of the Luciferase Activity in Living Cells
We used LacSwitch Inducible Mammalian Expression System (Stratagene) for
inducible expression of Per2. To perform IPTG-induced expression, Per2 was
subcloned into the pOPI3CAT vector. NIH 3T3 and U2OS cells were trans-
fected with the indicated combinations of expression vectors (hBmal1 pro-
moter-driven luciferase vector, pOPI3CAT vector for inducible expression of
Per2, and p30SS Lac-repressor-expression vector). The cells were treated
with 50 nM dexamethasone (2 hr) to synchronize cellular clocks and moved
into a photomultiplier tube assembly (LM2400, Hamamatsu). Light emissions
weremeasured using a photomultiplier tube in the presence of 0.1mM luciferin
and integrated for 1 min at 15 min intervals. Just before Per2 induction, a part
of the medium was collected from every culture dish for use as dilution
medium. Per2 expression was induced by administration of 2 mM IPTG to400 Cell Reports 8, 393–401, July 24, 2014 ª2014 The Authorstransfected cells. One hour after administration, IPTG-containing medium
was replaced with dilution medium to terminate Per2 induction.
Statistical Analysis
All data are presented as the mean ± SEM. The significance of differences be-
tween groups at each time point was analyzed by 2-way ANOVAwith repeated
measures, followed by post hoc analysis with Tukey’s test when statistical sig-
nificance between groups was evident. For the significance of two groups,
Student’s t test was used.
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